Showing results (181-190 of 6,760) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|December 16, 2011
Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized studyYanli Zhuang, Zhenhua Xu, Bart Frederick, et al.Clinical Therapeutics|December 20, 2011
Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese menGuoping Yang, Zhimin Fu, Xiaoping Chen, et al.Clinical Therapeutics|December 20, 2011
Understanding and teaching key concepts and tools of evidence-based medicine: perspectives of a clinician-researcher pharmaceutical physicianJamie KaragianisClinical Therapeutics|December 20, 2011
Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims studyHeather D Anderson, Wilson D Pace, Anne M Libby, et al.Clinical Therapeutics|February 17, 2012
A randomized, open-label, 5-period, balanced crossover study to evaluate the relative bioavailability of eltrombopag powder for oral suspension (PfOS) and tablet formulations and the effect of a high-calcium meal on eltrombopag pharmacokinetics when administered with or 2 hours before or after PfOSMary Beth Wire, Jennifer Bruce, Jennifer Gauvin, et al.Clinical Therapeutics|March 16, 2012
Effects of CYP4F2 polymorphism on response to warfarin during induction phase: a prospective, open-label, observational cohort studyIdit Bejarano-Achache, Liran Levy, Liat Mlynarsky, et al.Clinical Therapeutics|March 17, 2012
Validation of a genotyping method for analysis of TPMT polymorphismsManuel Román, Teresa Cabaleiro, Dolores Ochoa, et al.Clinical Therapeutics|February 28, 2012
Tolerability and dose proportional pharmacokinetics of pasireotide administered as a single dose or two divided doses in healthy male volunteers: a single-center, open-label, ascending-dose studyStephan Petersenn, Ke Hu, Mario Maldonado, et al.Clinical Therapeutics|March 3, 2012
The influence of sparse data sampling on population pharmacokinetics: a post hoc analysis of a pharmacokinetic study of morphine in healthy volunteersRobert E Ariano, Peter C Duke, Daniel S SitarClinical Therapeutics|September 23, 2008
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysisDiana M Sobieraj, C Michael White, Craig I ColemanPageof 676